Skip to main content
. 2023 Mar 13;25(2):179–198. doi: 10.5853/jos.2022.02936

Table 2.

Selected studies reporting the association between pre-treatment collateral status and outcomes after EVT of anterior circulation large vessel occlusion stroke

Study Patients (n) Collateral scale (method) Main findings
Highly Effective Reperfusion Evaluated in Multiple Endovascular Stroke trials (HERMES) collaboration [75] 1,764 (871 EVT, 893 control) Tan et al. [76] (sCTA, mCTA, or CE-MRA) Analyses suggested benefit with EVT across all strata of collateral circulation status; however, patients with poor collaterals were less likely to benefit from EVT than those with better collaterals (not statistically significant).
Endovascular Therapy Following Imaging Evaluation for Ischemic Stroke (DEFUSE 3) trial [77] 130 (65 EVT, 65 control) Tan et al. [76] (sCTA, mCTA, or CE-MRA) No significant association with good clinical outcome*, sICH, or death. Good collaterals were associated with significantly smaller ischemic core volume and less ischemic core growth.
Diffusion-Weighted Imaging or Computed Tomography Perfusion Assessment With Clinical Mismatch in the Triage of Wake-Up and Late Presenting Strokes Undergoing Neurointervention With Trevo (DAWN) trial [92] 161 (91 EVT, 70 control) Tan et al. [76] (CTA) Significant association between collateral status and infarct core at 24 h, ASPECTS at 24 h, successful revascularization (eTICI ≥2b), good functional outcome*, and death.
ASITN/SIR [78] (DSA)
Gerber et al. [79] 93 Tan et al. [76] Good collaterals were significantly associated with good clinical outcome* (OR 9.69; 95% CI 2.28–59.27; P=0.001).
Sedation versus Intubation for Endovascular Stroke TreAtment (SIESTA) trial [80] 104 Tan et al. [76] Good collaterals were significantly associated with smaller final infarct volume, improvement in the mean NIHSS at 24 h, and in-house mortality. No significant association was found with functional outcome or 3-month mortality.
Sallustio et al. [81] 135 Tan et al. [76] (CTA) Significant association between good collaterals and good functional outcome* (OR 2.13; 95% CI 1.44 to 3.15; P<0.001), lower mortality rate, lower rate of sICH, higher ASPECTS at 24 h, and higher NIHSS improvement at 24 h.
Christoforidis et al. [82] (DSA)
Park et al. [83] 119 Regional colateral scoring system [84] Good collaterals were an independent predictor of good functional outcome* (OR 5.14; 95% CI 1.62–16.26; P=0.005).
Renú et al. [85] 339 (257 EVT, 82 no EVT) Tan et al. [76] The benefit of EVT (reduction in infarct growth, functional outcome, and mortality) was significantly higher in patients with poor collaterals.
Weiss et al. [86] 84 Tan et al. [76] (sCTA) Good collaterals in the Miteff and Maas scores were significantly associated with good functional outcome*.
Miteff et al. [87] (sCTA)
Maas et al. [88] (sCTA)
Al-Dasuqi et al. [89] 283 Miteff et al. [87] (sCTA) Collateral grade was significantly associated with final infarct volume but not with functional outcome.
Optimizing Patient’s Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT) study [90] 361 (285 EVT, 76 medical management) mCTA [40] Collateral status was significantly associated with early infarct growth rate which in turn was significantly associated with functional outcome.
Endovascular Treatment in Ischemic Stroke (ETIS) Registry [91] 2,020 ASITN/SIR (DSA) Good collaterals were associated with successful reperfusion (OR 1.77; 95% CI 1.32–2.39; P<0.001), excellent reperfusion (OR 1.71; 95% CI 1.41–2.09; P<0.001), and good functional outcome* (OR 1.5; 95% CI 1.19–1.88; P<0.001), but not with sICH or mortality at 3 months.

EVT, endovascular thrombectomy; sCTA, single-phase computed tomography angiography; mCTA, multiphase computed tomography angiography; CE-MRA, contrast-enhanced magnetic resonance angiography; sICH, symptomatic intracranial hemorrhage; CTA, computed tomography angiography; ASITN/SIR, American Society of Interventional and Therapeutic Neuroradiology/Society of Interventional Radiology scale; DSA, digital subtraction angiography; ASPECTS, Alberta Stroke Program Early CT Score; eTICI, expanded Thrombolysis in Cerebral Infarction; OR, odds ratio; CI, confidence interval; NIHSS, National Institutes of Health Stroke Scale; mRS, modified Rankin Scale.

*

Good functional outcome: mRS ≤2 at 90 days.